Accendra Health
273 hedge funds and large institutions have $1.95B invested in Accendra Health in 2017 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 132 increasing their positions, 83 reducing their positions, and 36 closing their positions.
59% more repeat investments, than reductions
Existing positions increased: 132 | Existing positions reduced: 83
4% more call options, than puts
Call options by funds: $341K | Put options by funds: $327K
0.94% less ownership
Funds ownership: 100.01% → 99.08% (-0.94%)
4% less funds holding
Funds holding: 284 → 273 (-11)
8% less capital invested
Capital invested by funds: $2.11B → $1.95B (-$163M)
25% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$31.1M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$13.8M |
| 3 |
SCM
Scopia Capital Management
New York
|
+$12.7M |
| 4 |
Renaissance Technologies
New York
|
+$10.4M |
| 5 |
SCA
Secor Capital Advisors
New York
|
+$7.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$36.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$25M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$17M |
| 4 |
BlackRock
New York
|
-$16.3M |
| 5 |
GAM
Gotham Asset Management
New York
|
-$10.6M |
ACH Hedge Fund Activity: Q2 2017 in Review
273 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q2 2017, worth a combined $1.95B — down 7.7% from $2.11B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of ACH and 27 opened new positions — a net loss of 9 holders — while 83 trimmed existing stakes and 132 added.
The largest buyer was Balyasny Asset Management, adding an estimated $31.1M. The largest seller was Acadian Asset Management, cutting an estimated $36.2M.
- 273 institutional investors held Accendra Health (ACH) as of Q2 2017, down from 284 in Q1 2017.
- Funds reported $1.95B of Accendra Health stock for Q2 2017, down 7.7% quarter-over-quarter.
- 27 funds opened new Accendra Health positions in Q2 2017 and 36 closed out, a net change of -9 holders.
- The largest Accendra Health buyer in Q2 2017 was Balyasny Asset Management, an estimated $31.1M added.
- The largest Accendra Health seller in Q2 2017 was Acadian Asset Management, an estimated $36.2M sold.
Based on aggregated 13F filings for Q2 2017.